Shares of Cardio Diagnostics Holdings, Inc. (CDIO), an artificial intelligence-powered precision cardiovascular medicine company, are rising nearly 150% Tuesday morning following the launch of PrecisionCHD, a blood test for the early detection of coronary heart disease.
PrecisionCHD, a non-invasive test detects coronary heart disease with better than 75% sensitivity in both men and women. the company said.
CDIO is at $3.15 currently. It has traded in the range of $0.79-$10.25 in the last 1 year.
Source: Read Full Article
Lates News:
-
Ark Invest’s Spot Bitcoin ETF Inches Closer To SEC Approval
-
40,000 BTC from US Government Seizures in Motion: What Could It Mean for Bitcoin?
-
Myers Industries Shares Tanks In Spite Of Improved Quarterly Results
-
Digital Brands Up 9%, Concludes Sundry Acquisition
-
McGlone: Bitcoin's Major Price Hikes Waning?